| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005547818 |
| P356 | DOI | 10.1038/SJ.GT.3302875 |
| P698 | PubMed publication ID | 17036056 |
| P5875 | ResearchGate publication ID | 6759408 |
| P50 | author | Per-Ake Nygren | Q33274230 |
| P2093 | author name string | Lindholm L | |
| Olofsson S | |||
| Boulanger P | |||
| Hong SS | |||
| Myhre S | |||
| Henning P | |||
| Granio O | |||
| Tylö AS | |||
| P2860 | cites work | Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 |
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling | Q30810400 | ||
| Anti-idiotypic protein domains selected from protein A-based affibody libraries | Q30835904 | ||
| Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. | Q33782487 | ||
| Immune responses to adenovirus and adeno-associated virus in humans. | Q33874473 | ||
| Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain | Q34435244 | ||
| Occupancy and mechanism in antibody-mediated neutralization of animal viruses | Q34788252 | ||
| On the mechanism of staphylococcal protein A immunomodulation | Q36014924 | ||
| Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity | Q37362429 | ||
| Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter | Q38566509 | ||
| Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes | Q39592823 | ||
| Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry | Q39742044 | ||
| Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors | Q40008652 | ||
| Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity | Q40651696 | ||
| Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization | Q41120523 | ||
| Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. | Q42050497 | ||
| Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery | Q45231506 | ||
| Use of chimeric adenoviral vectors to assess capsid neutralization determinants. | Q45274472 | ||
| Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability | Q45731708 | ||
| Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients | Q45867352 | ||
| Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors | Q45887357 | ||
| Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein | Q46499919 | ||
| The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses | Q46635220 | ||
| Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity | Q47644096 | ||
| Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy | Q64380528 | ||
| P433 | issue | 4 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 376-381 | |
| P577 | publication date | 2006-10-12 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector | |
| P478 | volume | 14 |
| Q33565630 | Adenoviral vector immunity: its implications and circumvention strategies |
| Q37730252 | Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. |
| Q33279445 | Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy |
| Q33330736 | Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold |
| Q37714826 | An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes. |
| Q28744246 | Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction |
| Q26995655 | Circumventing antivector immunity: potential use of nonhuman adenoviral vectors |
| Q34280138 | Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation |
| Q55467684 | Designer Oncolytic Adenovirus: Coming of Age. |
| Q28534124 | Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In Vivo |
| Q35624010 | Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials. |
| Q39714576 | Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response |
| Q37310677 | Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model |
| Q42155660 | Novel subventricular zone early progenitor cell-specific adenovirus for in vivo therapy of central nervous system disorders reinforces brain stem cell heterogeneity. |
| Q26776553 | Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications |
| Q37603360 | Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors |
| Q36344901 | Polymeric oncolytic adenovirus for cancer gene therapy |
| Q36742911 | Protein-based tumor molecular imaging probes |
| Q45869559 | Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients |
Search more.